XML 53 R29.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 6 Months Ended
Dec. 26, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity with respect to Company-issued stock options since June 27, 2025:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as of December 26, 2025
Outstanding at June 27, 2025934 $12.71 $45.00 — 
Granted— — 
Exercised— — 
Canceled— — 
Outstanding at December 26, 2025934 12.71 45.00 2.32 years— 
Exercisable at December 26, 2025— $— $— — — 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 27, 2025:
 Non-vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Non-vested at June 27, 20251,742 $40.37 
Granted555 67.08 
Vested(405)39.86 
Forfeited(90)47.89 
Non-vested at December 26, 20251,802 $48.45 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Loss:
 Second Quarters EndedSix Months Ended
 December 26, 2025December 27, 2024December 26, 2025December 27, 2024
Cost of revenues$1,863 $(167)$3,623 $(54)
Selling, general and administrative7,026 6,317 13,322 10,928 
Research and development1,705 1,812 3,222 3,180 
Stock-based compensation expense before tax10,594 7,962 20,167 14,054 
Income taxes(1)
(2,860)(2,150)(5,445)(3,795)
Stock-based compensation expense, net of income taxes$7,734 $5,812 $14,722 $10,259 
(1) Federal and state statutory rate of 27%